Q: What is Gemcitabine used for?

Gemcitabine is used to treat: pancreatic cancer non-small cell lung cancer breast cancer and others

Q: How does Gemcitabine work?

Mechanism of Action Gemcitabine belongs to a class of drugs known as antimetabolites. These medications are designed to mimic the natural substances that cells use to grow and divide. Because cancer cells often divide more rapidly than healthy cells, they are more likely to take up these substances. Once gemcitabine enters a cancer cell, it undergoes chemical changes that allow it to interfere with the cell's internal processes in two primary ways: DNA Incorporation: The drug mimics one of the building blocks of DNA. When the cancer cell attempts to replicate its genetic material to divide, it mistakenly incorporates gemcitabine into the DNA strand. This stops the strand from growing further, which eventually leads to the death of the cell. Enzyme Inhibition: Gemcitabine also blocks an enzyme that the cell needs to produce the normal building blocks of DNA. By reducing the supply of these building blocks, the drug makes it even harder for the cancer cell to repair or replicate its DNA. This medication is most effective against cells that are actively synthesizing new DNA, a phase of the cell cycle where cancer cells spend a significant amount of time.

Q: What are the brand names for Gemcitabine?

Gemcitabine is sold under the brand name Gemzar .

Q: What are the active ingredients in Gemcitabine?

The active ingredient in Gemcitabine is gemcitabine .

Q: What are the side effects of Gemcitabine?

Common side effects of Gemcitabine may include: Nausea Fatigue Fever and others. Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Gemcitabine and how do I take it?

Administration Gemcitabine is given by a healthcare professional in a hospital or clinic setting. It is most commonly administered as an infusion into a vein (intravenously). The infusion process usually takes about 30 minutes. For certain types of bladder cancer, the medication may be placed directly into the bladder through a catheter. Dosing Schedule The frequency of treatment depends on the condition being treated and how the body responds to the medication. It is often given once a week or on specific days during a multi-week cycle. Healthcare providers will determine the exact schedule based on blood test results and the patient's overall health. Missed Doses Because this medication is administered by medical professionals, it is important to keep all scheduled appointments. If an appointment is missed, contact the healthcare provider immediately to reschedule the treatment.

Q: Is Gemcitabine safe during pregnancy and breastfeeding?

Pregnancy Gemcitabine can cause fetal harm when administered to a pregnant person. Based on its mechanism of action and animal studies, the drug may lead to birth defects or pregnancy loss. Healthcare providers typically require a pregnancy test for individuals of reproductive potential before starting treatment. Effective contraception is necessary to prevent pregnancy during and after treatment: Females: Use effective birth control during treatment and for 6 months after the final dose. Males: Use effective contraception if you have a female partner of reproductive potential during treatment and for 3 months after the final dose. If pregnancy occurs while using this medication, it is important to discuss the potential risks to the fetus with a healthcare professional immediately. Breastfeeding It is not known whether gemcitabine passes into human breast milk. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least one week after the last dose. Patients should discuss alternative feeding options with their healthcare team.

Q: What forms and strengths does Gemcitabine come in?

Intravenous Forms Gemcitabine is primarily administered as an intravenous infusion. It is available in the following formats: Lyophilized Powder: A sterile powder that requires reconstitution by a healthcare professional before use. Injectable Solution: A liquid formulation that may be ready-to-use or require dilution prior to administration. Intravesical Forms Gemcitabine is also available for administration directly into the urinary bladder through the following methods: Intravesical System: A specialized delivery device designed for placement within the bladder. Bladder Instillation Solution: A liquid form used for direct placement into the bladder cavity.

Question 1

What is Gemcitabine?

Accepted Answer

Gemcitabine belongs to a class of medications known as antimetabolites. It works by interfering with the development of new genetic material in cells, which prevents them from multiplying.

By disrupting the cell growth process, this medication helps to manage the spread of cancerous cells within the body.

Question 2

What is Gemcitabine used for?

Accepted Answer

Gemcitabine is used to treat:

pancreatic cancer
non-small cell lung cancer
breast cancer
and others

Question 3

How does Gemcitabine work?

Accepted Answer

Mechanism of Action

Gemcitabine belongs to a class of drugs known as antimetabolites. These medications are designed to mimic the natural substances that cells use to grow and divide. Because cancer cells often divide more rapidly than healthy cells, they are more likely to take up these substances.

Once gemcitabine enters a cancer cell, it undergoes chemical changes that allow it to interfere with the cell's internal processes in two primary ways:

DNA Incorporation: The drug mimics one of the building blocks of DNA. When the cancer cell attempts to replicate its genetic material to divide, it mistakenly incorporates gemcitabine into the DNA strand. This stops the strand from growing further, which eventually leads to the death of the cell.
Enzyme Inhibition: Gemcitabine also blocks an enzyme that the cell needs to produce the normal building blocks of DNA. By reducing the supply of these building blocks, the drug makes it even harder for the cancer cell to repair or replicate its DNA.

This medication is most effective against cells that are actively synthesizing new DNA, a phase of the cell cycle where cancer cells spend a significant amount of time.

Question 4

What are the brand names for Gemcitabine?

Accepted Answer

Gemcitabine is sold under the brand name Gemzar.

Question 5

What are the active ingredients in Gemcitabine?

Accepted Answer

The active ingredient in Gemcitabine is gemcitabine.

Question 6

What are the side effects of Gemcitabine?

Accepted Answer

Common side effects of Gemcitabine may include:

Nausea
Fatigue
Fever
and others.

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Gemcitabine?

Accepted Answer

Gemcitabine belongs to the antimetabolite chemotherapy drug class.

Question 8

What is the dosage of Gemcitabine and how do I take it?

Accepted Answer

Administration

Gemcitabine is given by a healthcare professional in a hospital or clinic setting. It is most commonly administered as an infusion into a vein (intravenously). The infusion process usually takes about 30 minutes. For certain types of bladder cancer, the medication may be placed directly into the bladder through a catheter.

Dosing Schedule

The frequency of treatment depends on the condition being treated and how the body responds to the medication. It is often given once a week or on specific days during a multi-week cycle. Healthcare providers will determine the exact schedule based on blood test results and the patient's overall health.

Missed Doses

Because this medication is administered by medical professionals, it is important to keep all scheduled appointments. If an appointment is missed, contact the healthcare provider immediately to reschedule the treatment.

Question 9

Is Gemcitabine safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Gemcitabine can cause fetal harm when administered to a pregnant person. Based on its mechanism of action and animal studies, the drug may lead to birth defects or pregnancy loss. Healthcare providers typically require a pregnancy test for individuals of reproductive potential before starting treatment.

Effective contraception is necessary to prevent pregnancy during and after treatment:

Females: Use effective birth control during treatment and for 6 months after the final dose.
Males: Use effective contraception if you have a female partner of reproductive potential during treatment and for 3 months after the final dose.

If pregnancy occurs while using this medication, it is important to discuss the potential risks to the fetus with a healthcare professional immediately.

Breastfeeding

It is not known whether gemcitabine passes into human breast milk. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least one week after the last dose. Patients should discuss alternative feeding options with their healthcare team.

Question 10

What forms and strengths does Gemcitabine come in?

Accepted Answer

Intravenous Forms

Gemcitabine is primarily administered as an intravenous infusion. It is available in the following formats:

Lyophilized Powder: A sterile powder that requires reconstitution by a healthcare professional before use.
Injectable Solution: A liquid formulation that may be ready-to-use or require dilution prior to administration.

Intravesical Forms

Gemcitabine is also available for administration directly into the urinary bladder through the following methods:

Intravesical System: A specialized delivery device designed for placement within the bladder.
Bladder Instillation Solution: A liquid form used for direct placement into the bladder cavity.

Question 11

What is the FDA approval status of Gemcitabine?

Accepted Answer

FDA Approval History

Gemcitabine was first approved by the U.S. Food and Drug Administration (FDA) in 1996. It is available as a generic medication and is administered intravenously or through specialized delivery systems for specific cancer types.

Approved Indications

The FDA has approved gemcitabine for the treatment of the following conditions:

Pancreatic Cancer: As a first-line treatment for patients with locally advanced or metastatic adenocarcinoma of the pancreas.
Non-Small Cell Lung Cancer (NSCLC): In combination with cisplatin for the first-line treatment of inoperable, locally advanced, or metastatic NSCLC.
Breast Cancer: In combination with paclitaxel for the first-line treatment of metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy.
Ovarian Cancer: In combination with carboplatin for the treatment of advanced ovarian cancer that has returned at least six months after finishing platinum-based therapy.
Bladder Cancer: In April 2024, the FDA approved a gemcitabine intravesical system for the treatment of adult patients with high-risk, non-muscle invasive bladder cancer (NMIBC) who are ineligible for or have elected not to undergo cystectomy.

Regulatory Classification and Safety

Gemcitabine is a prescription-only medication. It does not currently carry a boxed warning, but the FDA requires labeling to include serious warnings regarding myelosuppression (severe decreases in blood cell counts), pulmonary toxicity, and hemolytic uremic syndrome. The drug must be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Question 12

What should I know about Gemcitabine and cost?

Accepted Answer

Several factors contribute to the overall cost of gemcitabine therapy:

Generic vs. Brand Name: Gemcitabine is available as a generic medication, which is typically less expensive than the brand-name version, Gemzar.
Administration Setting: Because gemcitabine is administered by a healthcare professional in a hospital or clinic setting, the total cost usually includes facility fees and charges for the medical staff who provide the infusion or bladder treatment.
Dosage and Schedule: The total price depends on the specific dose required for the patient's weight and condition, as well as the number of treatment cycles prescribed by the doctor.

Most health insurance plans, including Medicare and Medicaid, provide coverage for gemcitabine when it is used for FDA-approved indications. Patients are encouraged to contact their insurance provider to determine their specific out-of-pocket responsibilities, such as copays or deductibles.

For those who are uninsured or have high out-of-pocket costs, some pharmaceutical manufacturers or non-profit organizations may offer patient assistance programs. Hospital financial counselors can often help patients identify these resources.

Gemcitabine

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Gemcitabine

Hospitals.net Disclosure